BrainsWay Ltd. is a healthcare company at the forefront of developing advanced medical technology for the treatment of brain health disorders. Specializing in Deep Transcranial Magnetic Stimulation (Deep TMS), BrainsWay aims to offer effective, non-invasive treatment options for conditions such as depression, obsessive-compulsive disorder, and smoking addiction. The firm's cutting-edge Deep TMS systems are designed to stimulate brain regions associated with various mental health conditions, thereby providing patients with alternative therapeutic solutions that differ from traditional pharmaceutical interventions.

BrainsWay's technological expertise prominently impacts the mental health sector by expanding treatment options available to practitioners and patients, potentially improving outcomes and quality of life. The company's focus on research and innovation drives its prominent role in the medical devices industry, supporting clinicians across numerous medical centers worldwide. With its innovative spirit, BrainsWay contributes significantly to the evolving landscape of neurotherapeutic solutions, establishing itself as an influential player in the global healthcare market.